Webinars

The Impact of COVID-19 on Colorectal Cancer Screening Activity

Prof. Iris Lansdorp-Vogelaar, Erasmus MC, moderated the session, which was an opportunity to learn about the impact of the pandemic on colorectal cancer screening activity by comparing the results of key process and early outcome indicators in 2019 and 2020. Dr. Carlo Senore presented quantitative data provided by programs participating in the survey launched by the ICSN Colorectal Cancer Screening Interest Group. Dr. Eleonora Feletto, The Daffodil Center, talked about findings from the International Partnership for Resilience in Cancer Systems (I-PaRCS), and Prof. Nancy Baxter, University of Melbourne, discussed the NIMBLE approach, a conceptual framework to understand the challenges and adaptive approaches taken by colorectal cancer screening programs to face the pandemic. The webinar concluded with an interactive panel discussion with program coordinators of CRC screening programs that have shown an effective response to the COVID-19 emergency.

Slide sets:

Carlo Senore: Results of the ICSN Colorectal Cancer Screening Interest Group Survey on the Impact of COVID-19

Eleonora Feletto: Findings from the International Partnership for Resilience in Cancer Systems

Nancy Baxter: The NIMBLE Approach to Adapt Colorectal Cancer Screening

Dominika Novak Mlakar: Impact of COVID-19 on Colorectal Cancer Screening Activity in Slovenia

Iris Seriese: Impact COVID-19 on CRC Screening – Netherlands

Isabel Portillo: Strategies to Mitigate the Impact of COVID-19 on the Colorectal Cancer Screening Programme in the Basque Country-Spain

Impact of COVID-19 on Cervical Cancer Screening in Low- and Middle-Income Countries

Over 80% of cervical cancer incidence and deaths from cervical cancer occur in low- and middle- income countries (LMICs). The COVID-19 pandemic led to the disruption of health services, including cervical screening provision, in many countries. This webinar offered an opportunity for the screening community to learn about, and reflect on, the impact of the COVID-19 pandemic on cervical cancer screening.

A keynote presentation from Dr. Partha Basu, Deputy Head of the Early Detection, Prevention and Infections Branch at the International Agency for Research on Cancer (IARC), provided a high-level overview of global issues and the possible impact on achieving WHO cervical cancer elimination goals, as well as lessons learned on the ground. The program followed with presentations reporting on local programmes and adaptations to COVID-19 by Jane Matambo, manager of cancer screening services at the Center for Infectious Disease Research in Zambia, Dr. Muluken Gizaw, Assistant Professor from Addis Ababa University in Ethiopia, and Dr. Karla Alfaro, Medical Director at Basic Health International in El Salvador.

Slide sets:

Christine Campbell: The Impact of COVID-19 on Cervical Cancer Screening in Low- and Middle-Income Countries

Partha Basu: Impact of Covid-19 on cervical cancer screening programmes in the LMICs

Jane Matambo: The Impact of Covid-19 in Zambia Cervical Cancer Prevention Program

Muluken Gizaw: Impact of deferring cervical cancer screening in connection to COVID-19 The case of Ethiopia

Karla Alfaro: Impact of COVID on Cervical Cancer Screening in El Salvador

Early Assessment of the Effects of COVID-19 on Cancer Screening

This ICSN webinar focused on the results of the ICSN survey assessing the effects of the first wave of COVID-19 on cancer screening around the world. Douglas Puricelli Perin, MPH, ICSN Program Coordinator presented the results of the ICSN survey together with a literature review about the disruptions in cancer screening caused by previous disasters. In addition, Iris Lansdorp-Vogelaar, PhD, Associate Professor at the Department of Public Health of Erasmus Medical Center, and colleagues from the COVID-19 and Cancer Global Modeling Consortium presented their latest work.

Slide sets:

Douglas Perin: ICSN Survey on the Impact of COVID-19 on Cancer Screening

Iris Lansdorp-Vogelaar: COVID-19 and Cancer Global Modeling Consortium (CCGMC)

Jonine Figueroa: CCGMC – Breast Cancer

Alejandra Castañon: CCGMC – Cervical Cancer

Veerle Coupé: CCGMC – Colorectal Cancer

Publications

Previous 5 years:

AuthorsTitle 
Segnan N, et al.Comparing Colorectal Cancer Screening Outcomes in the International Cancer Screening Network: A Consortium Proposal.
Puricelli Perin DM, et al.Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey.
Puricelli Perin DM, et al.Interruption of cancer screening services due to COVID-19 pandemic: lessons from previous disasters.
Castanon A, et al.Exposure Definition in Case-Control Studies of Cervical Cancer Screening: A Systematic Literature Review.
Doria-Rose VP, et al.Measures of longitudinal adherence to fecal-based colorectal cancer screening: Literature review and recommended approaches.
Bulliard JL, et al.Breast cancer screening and overdiagnosis.
Ponti A, et al.Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions: evidence from an international multi-centre study.
Broeders M, et al.Importance of International Networking and Comparative Research in Screening to Meet the Global Challenge of Cancer Control.
Vogel AL, et al.Understanding the Value of International Research Networks: An Evaluation of the International Cancer Screening Network of the US National Cancer Institute.
Puricelli Perin DM, et al.Assessing Knowledge Sharing in Cancer Screening Among High-, Middle-, and Low-Income Countries: Insights From the International Cancer Screening Network.
Sivaram S, et al.Population-based cancer screening programmes in low-income and middle-income countries: regional consultation of the International Cancer Screening Network in India.

Pre-2017:

AuthorsTitle 
Klabunde C, et al.Participation rates for organized colorectal cancer screening programmes: an international comparison
Bulliard JL, et al.Sorting out measures and definitions of screening participation to improve comparability: the example of colorectal cancer.
Ponti A, et al.International variation in management of screen-detected ductal carcinoma in situ of the breast.
Lynge E, et al. Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network.
Dowling EC, et al.Breast and cervical cancer screening programme implementation in 16 countries.
Cox B, et al.Recording of hormone therapy and breast density in breast screening programs: summary and recommendations of the International Cancer Screening Network.
Hofvind S, et al.Comparing interval breast cancer rates in Norway and North Carolina: results and challenges.
Geller BM, et al.Communicating with women about mammography.
Klabunde CN, et al.Evaluating Population-Based Screening Mammography Programs Internationally.
Zapka JG, et al.Print information to inform decisions about mammography screening participation in 16 countries with population-based programs.
Bulliard JL, et al.Methodological issues in international comparison of interval breast cancers.
Yankaskas BC, et al.International Breast Cancer Screening Network. International comparison of performance measures for screening mammography: can it be done?
Hendrick RE, et al.Technical quality control practices in mammography screening programs in 22 countries.
Klabunde C, et al.Quality assurance for screening mammography: an international comparison.
Klabunde CN, et al.Quality assurance for screening mammography data collection systems in 22 countries.
Ballard-Barbash R, et al.Breast cancer screening in 21 countries: delivery of services, notification of results and outcomes ascertainment.
Shapiro S, et al.Breast cancer screening programmes in 22 countries: current policies, administration and guidelines.

External Resources

Covid-19 and Cancer Global Modelling Consortium: https://ccgmc.org/

European Commission Initiative on Breast Cancer: https://healthcare-quality.jrc.ec.europa.eu/

European Commission Initiative on Colorectal Cancer: https://healthcare-quality.jrc.ec.europa.eu/sites/default/files/ECICC/ECICC_flyer_March-2021.pdf

IARC: https://screening.iarc.fr/

NCI-Center for Global Health: https://www.cancer.gov/about-nci/organization/cgh